Cargando…
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676082/ https://www.ncbi.nlm.nih.gov/pubmed/26256637 http://dx.doi.org/10.1038/leu.2015.217 |
| _version_ | 1782405106623315968 |
|---|---|
| author | Strefford, JC Kadalayil, L Forster, J Rose-Zerilli, MJJ Parker, A Lin, TT Heppel, N Norris, K Gardiner, A Davies, Z Gonzalez de Castro, D Else, M Steele, AJ Parker, H Stankovic, T Pepper, C Fegan, C Baird, D Collins, A Catovsky, D Oscier, DG |
| author_facet | Strefford, JC Kadalayil, L Forster, J Rose-Zerilli, MJJ Parker, A Lin, TT Heppel, N Norris, K Gardiner, A Davies, Z Gonzalez de Castro, D Else, M Steele, AJ Parker, H Stankovic, T Pepper, C Fegan, C Baird, D Collins, A Catovsky, D Oscier, DG |
| author_sort | Strefford, JC |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4676082 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46760822016-05-18 Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial Strefford, JC Kadalayil, L Forster, J Rose-Zerilli, MJJ Parker, A Lin, TT Heppel, N Norris, K Gardiner, A Davies, Z Gonzalez de Castro, D Else, M Steele, AJ Parker, H Stankovic, T Pepper, C Fegan, C Baird, D Collins, A Catovsky, D Oscier, DG Leukemia Article 2015-08-10 2015-12 /pmc/articles/PMC4676082/ /pubmed/26256637 http://dx.doi.org/10.1038/leu.2015.217 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
| spellingShingle | Article Strefford, JC Kadalayil, L Forster, J Rose-Zerilli, MJJ Parker, A Lin, TT Heppel, N Norris, K Gardiner, A Davies, Z Gonzalez de Castro, D Else, M Steele, AJ Parker, H Stankovic, T Pepper, C Fegan, C Baird, D Collins, A Catovsky, D Oscier, DG Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial |
| title | Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial |
| title_full | Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial |
| title_fullStr | Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial |
| title_full_unstemmed | Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial |
| title_short | Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial |
| title_sort | telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the uk lrf cll4 trial |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676082/ https://www.ncbi.nlm.nih.gov/pubmed/26256637 http://dx.doi.org/10.1038/leu.2015.217 |
| work_keys_str_mv | AT streffordjc telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT kadalayill telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT forsterj telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT rosezerillimjj telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT parkera telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT lintt telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT heppeln telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT norrisk telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT gardinera telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT daviesz telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT gonzalezdecastrod telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT elsem telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT steeleaj telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT parkerh telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT stankovict telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT pepperc telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT feganc telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT bairdd telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT collinsa telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT catovskyd telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial AT oscierdg telomerelengthpredictsprogressionandoverallsurvivalinchroniclymphocyticleukemiadatafromtheuklrfcll4trial |